表紙
市場調查報告書

全球感染控制市場:到2027年的行業趨勢和預測

Global Infection Control Market - Industry Trends and Forecast to 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 953404
出版日期 內容資訊 英文 404 Pages
商品交期: 最快1-2個工作天內
價格
全球感染控制市場:到2027年的行業趨勢和預測 Global Infection Control Market - Industry Trends and Forecast to 2027
出版日期: 2020年07月01日內容資訊: 英文 404 Pages
簡介

預計在2020年至2027年的預測期內,全球感染控制市場將以14%的複合年增長率穩定增長。該市場的主要增長因素是人口老齡化的增加和醫院感染的流行。

本報告調查了全球感染控制措施市場,包括市場增長和限制,挑戰和機遇,按產品/使用/分銷渠道/最終用戶/地區進行的市場分析,競爭態勢和主要趨勢。我們提供諸如公司簡介之類的信息。

目錄

第1章簡介

第2章市場細分

第3章執行摘要

第4章重要注意事項

第5章監管情景

  • FDA規定
  • 消毒器
  • 消毒裝置
  • 化學/物理消毒裝置
  • 紫外線(UV)消毒裝置
  • 空氣淨化器

第6章市場概述

  • 生長因子
    • 醫院感染導致感染率上升
    • 老年人口增加
    • 提高個人防護裝備的意識
    • 政府戰略計劃
    • 對手術的需求增加
  • 抑制因子
    • 對後處理設備安全性的擔憂
    • 缺乏非熟練勞動力
  • 市場機會
    • 技術進步
    • 新興國家的經濟
    • 醫院和診所數量增加
  • 挑戰
    • 儲存和運輸的安全注意事項
    • 先進醫療設備的滅菌

第7章:COVID-19大流行對市場的影響

  • 價格影響
  • 按需投放
  • 對供應鏈的影響
  • 製造商的戰略決策
  • 結論

第8章市場分析:按產品

  • 概述
  • 無菌產品
    • 消毒器
    • 耗材和配件
  • 清潔和消毒產品
    • 消毒劑
    • 清潔/消毒裝置
    • 潤滑劑/清潔液
    • 消毒/清潔配件
  • 個人防護裝備
    • 醫用無紡布
    • 封面和封底
    • 面罩
    • 護目鏡
    • 其他
  • 內窺鏡後處理產品
    • 內窺鏡後處理裝置
    • 內窺鏡後處理耗材
  • 抗菌表面
  • 其他

第9章市場分析:按應用

  • 概述
  • 手術器械
  • 內窺鏡
  • 超聲波探頭
  • 其他

第10章市場分析:按分銷渠道

  • 概述
  • 直接出價
  • 第三方分銷商
  • 零售

第11章最終用戶的市場分析

  • 概述
  • 醫院
  • 診所
  • 醫療器械公司
  • 製藥和生物技術公司
  • 實驗室
  • 其他

第12章市場分析:按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 瑞士
    • 比利時
    • 土耳其
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳大利亞
    • 韓國
    • 印度
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲
  • 中東/非洲
    • 沙特阿拉伯
    • 南非
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及
    • 其他

第13章世界市場與公司狀況

  • 公司佔有率分析:全球
  • 公司佔有率分析:北美
  • 公司佔有率分析:歐洲
  • 公司佔有率分析:亞太地區

第14章公司簡介

  • 3M
  • CARDINAL HEALTH
  • RECKITT BENCKISER GROUP PLC
  • STERIS PLC
  • ECOLAB
  • STRYKER
  • B. BRAUN MELSUNGEN AG
  • GETINGE AB
  • OLYMPUS CORPORATION OF THE AMERICAS (レэ⑦еЗ株式會社)
  • CANTEL MEDICAL
  • THE CLOROX COMPANY
  • CISA PRODUCTION S.R.L. UNIPERSONALE
  • COLTENE GROUP
  • COVALON TECHNOLOGIES LTD.
  • MATACHANA GROUP
  • MELAG MEDIZINTECHNIK GMBH & CO. KG
  • METREX RESEARCH, LLC.
  • MMM GROUP
  • PAL INTERNATIONAL
  • SKYTRON, LLC
  • STEELCO S.P.A.
  • TERRAGENE SA

第15章問卷調查

第16章相關報告

目錄

Global infection control market is projected to register a healthy CAGR of 14.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Global Infection Control Market, By Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Antimicrobial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific, Brazil, Argentina, and Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global infection control market are:

  • Increase in geriatric population
  • Increase in prevalence of hospital acquired infection

Market Players:

The key market players for global infection control market are listed below:

  • 3M
  • STERIS plc
  • Getinge AB
  • MMM Group
  • Cantel Medical
  • MATACHANA GROUP
  • Ecolab
  • BELIMED, INC.
  • Cardinal Health
  • Steelco S.p.A.
  • Reckitt Benckiser Group plc
  • Metrex Research, LLC.
  • Stryker
  • B. Braun Melsungen AG
  • Covalon Technologies Ltd.
  • SKYTRON, LLC
  • Olympus Corporation of the Americas (A Subsidiary of Olympus Corporation)
  • COLTENE Group
  • Pal International
  • MELAG Medizintechnik GmbH & Co. KG
  • Cisa Production S.r.l. Unipersonale
  • TERRAGENE SA
  • The Clorox Company

TABLE OF CONTENTS

1 INTRODUCTION 48

  • 1.1 OBJECTIVES OF THE STUDY 48
  • 1.2 MARKET DEFINITION 48
  • 1.3 OVERVIEW OF GLOBAL INFECTION CONTROL MARKET 48
  • 1.4 LIMITATION 50
  • 1.5 MARKETS COVERED 50

2 MARKET SEGMENTATION 53

  • 2.1 MARKETS COVERED 53
  • 2.2 GEOGRAPHICAL SCOPE 54
  • 2.3 YEARS CONSIDERED FOR THE STUDY 55
  • 2.4 CURRENCY AND PRICING 55
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
  • 2.6 MULTIVARIATE MODELLING 59
  • 2.7 MARKET APPLICATION COVERAGE GRID 60
  • 2.8 PRODUCT LIFELINE CURVE 61
  • 2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 62
  • 2.10 DBMR MARKET POSITION GRID 63
  • 2.11 VENDOR SHARE ANALYSIS 64
  • 2.12 SECONDARY SOURCES 65
  • 2.13 ASSUMPTIONS 65

3 EXECUTIVE SUMMARY 66

4 PREMIUM INSIGHTS 69

5 REGULATORY SCENARIO 71

  • 5.1 FDA REGULATION 71
  • 5.2 STERILIZERS 71
  • 5.3 DISINFECTANT DEVICES 71
  • 5.4 CHEMICAL/PHYSICAL DISINFECTANT DEVICES 72
  • 5.5 ULTRAVIOLET (UV) DISINFECTING DEVICES 72
  • 5.6 AIR PURIFIERS 73

6 MARKET OVERVIEW 74

  • 6.1 DRIVERS 76
    • 6.1.1 INCREASE IN PREVALANCE OF HOSPITAL ACQUIRED INFECTION 76
    • 6.1.2 INCREASING GERIATRIC POPULATION 77
    • 6.1.3 RISING AWARENESS ABOUT PERSONAL PROTECTIVE EQUIPMENT 78
    • 6.1.4 STRATEGIC INITIATIVES BY THE GOVERNMENT 79
    • 6.1.5 GROWING DEMAND OF SURGICAL PROCEDURES 79
  • 6.2 RESTRAINTS 80
    • 6.2.1 APPREHENSIONS CONCERNING THE SAFETY OF REPROCESSED INSTRUMENTS 80
    • 6.2.2 LACK OF UNSKILLED LABOR 80
  • 6.3 OPPORTUNITIES 80
    • 6.3.1 TECHNOLOGICAL ADVANCEMENT 80
    • 6.3.2 EMERGING ECONOMY AMONG THE DEVELOPING NATIONS 81
    • 6.3.3 INCREASE IN NUMBER OF HOSPITALS AND CLINICS 81
  • 6.4 CHALLENGES 82
    • 6.4.1 SAFETY CONSIDERATION IN STORAGE & TRANSPORTATION 82
    • 6.4.2 STERLIZATION OF ADVANCED MEDICAL INSTRUMENTS 82

7 IMPACT OF COVID-19 PANDEMIC ON THE GLOBAL INFECTION CONTROL MARKET 83

  • 7.1 PRICE IMPACT 83
  • 7.2 IMPACT ON DEMAND 83
  • 7.3 IMPACT ON SUPPLY CHAIN 84
  • 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 84
  • 7.5 CONCLUSION 84

8 GLOBAL INFECTION CONTROL MARKET, BY PRODUCT 85

  • 8.1 OVERVIEW 86
  • 8.2 STERILIZATION PRODUCTS 89
    • 8.2.1 STERILIZATION EQUIPMENT 90
      • 8.2.1.1 LOW TEMPERATURE STERILIZATION 90
        • 8.2.1.1.1 HYDROGEN PEROXIDE STERILIZATION 91
        • 8.2.1.1.2 ETHYLENE OXIDE STERILIZATION (ETO) 91
        • 8.2.1.1.3 FORMALDEHYDE STERILIZATION 91
        • 8.2.1.1.4 OTHER LOW-TEMPERATURE STERILIZATION 91
      • 8.2.1.2 HEAT STERILIZATION EQUIPMENT 91
        • 8.2.1.2.1 MOIST HEAT STERILIZERS 91
        • 8.2.1.2.1 DRY HEAT STERILIZERS 92
      • 8.2.1.3 RADIATION STERILIZATION 92
      • 8.2.1.4 FILTRATION STERILIZATION 92
      • 8.2.1.5 OTHER EQUIPMENT 92
    • 8.2.2 CONSUMABLES AND ACCESSORIES 92
      • 8.2.2.1 CHEMICAL INDICATORS 92
      • 8.2.2.2 BIOLOGICAL INDICATORS 92
      • 8.2.2.3 PACKAGING ACCESSORIES 93

  • 8.3 CLEANING AND DISINFECTION PRODUCTS 93
    • 8.3.1 DISINFECTANTS 94
      • 8.3.1.1 BY PRODUCT TYPE 94
        • 8.3.1.1.1 HAND DISINFECTANTS 94
        • 8.3.1.1.2 SURFACE DISINFECTANTS 94
        • 8.3.1.1.3 SKIN DISINFECTANTS 95
        • 8.3.1.1.4 INSTRUMENT DISINFECTANTS 95
      • 8.3.1.2 BY FORMULATION 95
        • 8.3.1.2.1 LIQUID DISINFECTANTS 95
        • 8.3.1.2.2 DISINFECTANT SPRAYS 95
      • 8.3.1.3 BY EPA CLASSIFICATION 95
        • 8.3.1.3.1 HIGH-LEVEL DISINFECTANTS 96
        • 8.3.1.3.2 LOW-LEVEL DISINFECTANTS 96
        • 8.3.1.3.3 INTERMEDIATE-LEVEL DISINFECTANTS 96
    • 8.3.2 CLEANING AND DISINFECTION EQUIPMENT 96
      • 8.3.2.1 WASHER DISINFECTORS 97
      • 8.3.2.2 FLUSHER DISINFECTORS 97
      • 8.3.2.3 UV-RAY DISINFECTORS 97
      • 8.3.2.4 ULTRASONIC CLEANERS 97
      • 8.3.2.5 OTHER CLEANING AND DISINFECTION EQUIPMENT 97
    • 8.3.3 LUBRICANTS AND CLEANING SOLUTIONS 97
    • 8.3.4 DISINFECTION AND CLEANING ACCESSORIES 98
  • 8.4 PERSONAL PROTECTIVE BARRIERS 98
    • 8.4.1 MEDICAL NONWOVENS 99
      • 8.4.1.1 SURGICAL DRAPES 99
      • 8.4.1.2 SURGICAL GOWNS 99
      • 8.4.1.3 FACE MASKS 99
    • 8.4.2 COVERS AND CLOSURES 100
    • 8.4.3 FACE SHIELDS 100
    • 8.4.4 GOGGLES 100
    • 8.4.5 OTHERS 100
  • 8.5 ENDOSCOPE REPROCESSING PRODUCTS 100
    • 8.5.1 ENDOSCOPE REPROCESSING EQUIPMENT 101
      • 8.5.1.1 AUTOMATED ENDOSCOPE REPROCESSORS 102
      • 8.5.1.2 ENDOSCOPE TRACKING SYSTEMS 102
      • 8.5.1.3 OTHER ENDOSCOPE REPROCESSING PRODUCTS 102
    • 8.5.2 ENDOSCOPE REPROCESSING CONSUMABLES 102
  • 8.6 ANTI-MICROBIAL SURFACES 102
  • 8.7 OTHER INFECTION CONTROL PRODUCTS 103

9 GLOBAL INFECTION CONTROL MARKET , BY APPLICATION 104

  • 9.1 OVERVIEW 105
  • 9.2 SURGICAL INSTRUMENTS 108
  • 9.3 ENDOSCOPES 108
  • 9.4 ULTRASOUND PROBES 109
  • 9.5 OTHERS 110

10 GLOBAL INFECTION CONTROL MARKET, BY DISTRIBUTION CHANNEL 111

  • 10.1 OVERVIEW 112
  • 10.2 DIRECT TENDER 114
  • 10.3 THIRD PARTY DISTRIBUTORS 115
  • 10.4 RETAIL SALES 116

11 GLOBAL INFECTION CONTROL MARKET, BY END USER 117

  • 11.1 OVERVIEW 118
  • 11.2 HOSPITALS 120
  • 11.3 CLINICS 121
  • 11.4 MEDICAL DEVICE COMPANIES 121
  • 11.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 122
  • 11.6 LABORATORIES 123
  • 11.7 OTHERS 124

12 GLOBAL INFECTION CONTROL MARKET, BY GEOGRAPHY 125

  • 12.1 OVERVIEW 126
  • 12.2 NORTH AMERICA 131
    • 12.2.1 U.S. 139
    • 12.2.2 CANADA 144
    • 12.2.3 MEXICO 149
  • 12.3 EUROPE 154
    • 12.3.1 GERMANY 163
    • 12.3.2 FRANCE 168
    • 12.3.3 U.K 173
    • 12.3.4 ITALY 178
    • 12.3.5 SPAIN 183
    • 12.3.6 NETHERLANDS 188
    • 12.3.7 RUSSIA 193
    • 12.3.8 SWITZERLAND 198
    • 12.3.9 BELGIUM 203
    • 12.3.10 TURKEY 208
    • 12.3.11 REST OF EUROPE 213
  • 12.4 ASIA-PACIFIC 214
    • 12.4.1 JAPAN 223
    • 12.4.2 CHINA 228
    • 12.4.3 AUSTRALIA 233
    • 12.4.4 SOUTH KOREA 238
    • 12.4.5 INDIA 243
    • 12.4.6 SINGAPORE 248
    • 12.4.7 THAILAND 253
    • 12.4.8 MALAYSIA 258
    • 12.4.9 INDONESIA 263
    • 12.4.10 PHILIPPINES 268
    • 12.4.11 REST OF ASIA PACIFIC 273
  • 12.5 SOUTH AMERICA 274
    • 12.5.1 BRAZIL 282
    • 12.5.2 ARGENTINA 287
    • 12.5.3 REST OF SOUTH AMERICA 292
  • 12.6 MIDDLE EAST & AFRICA 293
    • 12.6.1 SAUDI ARABIA 302
    • 12.6.2 SOUTH AFRICA 307
    • 12.6.3 UAE 312
    • 12.6.4 ISRAEL 317
    • 12.6.5 EGYPT 322
    • 12.6.6 REST OF MIDDLE EAST & AFRICA 327

13 GLOBAL INFECTION CONTROL MARKET, COMPANY LANDSCAPE 328

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 328
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 329
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 330
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 331

14 COMPANY PROFILE 332

  • 14.1 3M 332
    • 14.1.1 COMPANY SNAPSHOT 332
    • 14.1.2 REVENUE ANALYSIS 333
    • 14.1.3 COMPANY SHARE ANALYSIS 333
    • 14.1.4 PRODUCT PORTFOLIO 334
    • 14.1.5 RECENT DEVELOPMENTS 335
  • 14.2 CARDINAL HEALTH 336
    • 14.2.1 COMPANY SNAPSHOT 336
    • 14.2.2 REVENUE ANALYSIS 336
    • 14.2.3 COMPANY SHARE ANALYSIS 337
    • 14.2.4 PRODUCT PORTFOLIO 337
    • 14.2.5 RECENT DEVELOPMENTS 338
  • 14.3 RECKITT BENCKISER GROUP PLC 339
    • 14.3.1 COMPANY SNAPSHOT 339
    • 14.3.2 REVENUE ANALYSIS 339
    • 14.3.3 COMPANY SHARE ANALYSIS 340
    • 14.3.4 PRODUCT PORTFOLIO 340
    • 14.3.5 RECENT DEVELOPMENTS 341
  • 14.4 STERIS PLC 342
    • 14.4.1 COMPANY SNAPSHOT 342
    • 14.4.2 REVENUE ANALYSIS 342
    • 14.4.3 COMPANY SHARE ANALYSIS 343
    • 14.4.4 PRODUCT PORTFOLIO 343
    • 14.4.5 RECENT DEVELOPMENTS 344
  • 14.5 ECOLAB 345
    • 14.5.1 COMPANY SNAPSHOT 345
    • 14.5.2 REVENUE ANALYSIS 346
    • 14.5.3 COMPANY SHARE ANALYSIS 346
    • 14.5.4 PRODUCT PORTFOLIO 347
    • 14.5.5 RECENT DEVELOPMENTS 349
  • 14.6 STRYKER 350
    • 14.6.1 COMPANY SNAPSHOT 350
    • 14.6.2 REVENUE ANALYSIS 350
    • 14.6.3 PRODUCT PORTFOLIO 351
    • 14.6.4 RECENT DEVELOPMENTS 351
  • 14.7 B. BRAUN MELSUNGEN AG 353
    • 14.7.1 COMPANY SNAPSHOT 353
    • 14.7.2 REVENUE ANALYSIS 353
    • 14.7.3 PRODUCT PORTFOLIO 354
    • 14.7.4 RECENT DEVELOPMENTS 355
  • 14.8 GETINGE AB 356
    • 14.8.1 COMPANY SNAPSHOT 356
    • 14.8.2 REVENUE ANALYSIS 356
    • 14.8.3 PRODUCT PORTFOLIO 357
    • 14.8.4 RECENT DEVELOPMENTS 358
  • 14.9 OLYMPUS CORPORATION OF THE AMERICAS (A SUBSIDIARY OF OLYMPUS CORPORATION) 360
    • 14.9.1 COMPANY SNAPSHOT 360
    • 14.9.2 REVENUE ANALYSIS 360
    • 14.9.3 PRODUCT PORTFOLIO 360
    • 14.9.4 RECENT DEVELOPMENTS 361
  • 14.10 CANTEL MEDICAL 362
    • 14.10.1 COMPANY SNAPSHOT 362
    • 14.10.2 REVENUE ANALYSIS 363
    • 14.10.3 PRODUCT PORTFOLIO 363
    • 14.10.4 RECENT DEVELOPMENT 369
  • 14.11 THE CLOROX COMPANY 370
    • 14.11.1 COMPANY SNAPSHOT 370
    • 14.11.2 REVENUE ANALYSIS 370
    • 14.11.3 PRODUCT PORTFOLIO 371
    • 14.11.4 RECENT DEVELOPMENT 372
  • 14.12 CISA PRODUCTION S.R.L. UNIPERSONALE 373
    • 14.12.1 COMPANY SNAPSHOT 373
    • 14.12.2 PRODUCT PORTFOLIO 373
    • 14.12.3 RECENT DEVELOPMENTS 374
  • 14.13 COLTENE GROUP 375
    • 14.13.1 COMPANY SNAPSHOT 375
    • 14.13.2 REVENUE ANALYSIS 375
    • 14.13.3 PRODUCT PORTFOLIO 376
    • 14.13.4 RECENT DEVELOPMENTS 376
  • 14.14 COVALON TECHNOLOGIES LTD. 377
    • 14.14.1 COMPANY SNAPSHOT 377
    • 14.14.2 REVENUE ANALYSIS 377
    • 14.14.3 PRODUCT PORTFOLIO 378
    • 14.14.4 RECENT DEVELOPMENTS 378
  • 14.15 MATACHANA GROUP 379
    • 14.15.1 COMPANY SNAPSHOT 379
    • 14.15.2 PRODUCT PORTFOLIO 379
    • 14.15.3 RECENT DEVELOPMENTS 380
  • 14.16 MELAG MEDIZINTECHNIK GMBH & CO. KG 381
    • 14.16.1 COMPANY SNAPSHOT 381
    • 14.16.2 PRODUCT PORTFOLIO 381
    • 14.16.3 RECENT DEVELOPMENTS 382
  • 14.17 METREX RESEARCH, LLC. 383
    • 14.17.1 COMPANY SNAPSHOT 383
    • 14.17.2 PRODUCT PORTFOLIO 383
    • 14.17.3 RECENT DEVELOPMENTS 384
  • 14.18 MMM GROUP 385
    • 14.18.1 COMPANY SNAPSHOT 385
    • 14.18.2 PRODUCT PORTFOLIO 385
    • 14.18.3 RECENT DEVELOPMENTS 386
  • 14.19 PAL INTERNATIONAL 387
    • 14.19.1 COMPANY SNAPSHOT 387
    • 14.19.2 PRODUCT PORTFOLIO 387
    • 14.19.3 RECENT DEVELOPMENTS 388
  • 14.20 SKYTRON, LLC 389
    • 14.20.1 COMPANY SNAPSHOT 389
    • 14.20.2 PRODUCT PORTFOLIO 389
    • 14.20.3 RECENT DEVELOPMENTS 390
  • 14.21 STEELCO S.P.A. 391
    • 14.21.1 COMPANY SNAPSHOT 391
    • 14.21.2 PRODUCT PORTFOLIO 391
    • 14.21.3 RECENT DEVELOPMENTS 395
  • 14.22 TERRAGENE SA 397
    • 14.22.1 COMPANY SNAPSHOT 397
    • 14.22.2 PRODUCT PORTFOLIO 397
    • 14.22.3 RECENT DEVELOPMENTS 399

15 QUESTIONNAIRE 401

16 RELATED REPORTS 404

LIST OF FIGURES

  • FIGURE 1 GLOBAL INFECTION CONTROL MARKET: SEGMENTATION 53
  • FIGURE 2 GLOBAL INFECTION CONTROL MARKET: DATA TRIANGULATION 56
  • FIGURE 3 GLOBAL INFECTION CONTROL MARKET: DROC ANALYSIS 57
  • FIGURE 4 GLOBAL INFECTION CONTROL MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS 58
  • FIGURE 5 GLOBAL INFECTION CONTROL MARKET : COMPANY RESEARCH ANALYSIS 58
  • FIGURE 6 GLOBAL INFECTION CONTROL MARKET: MARKET APPLICATION COVERAGE GRID 60
  • FIGURE 7 GLOBAL INFECTION CONTROL MARKET: INTERVIEW DEMOGRAPHICS 62
  • FIGURE 8 GLOBAL INFECTION CONTROL MARKET: DBMR MARKET POSITION GRID 63
  • FIGURE 9 GLOBAL INFECTION CONTROL MARKET: VENDOR SHARE ANALYSIS 64
  • FIGURE 10 GLOBAL INFECTION CONTROL MARKET: SEGMENTATION 67
  • FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL INFECTION CONTROL MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 68
  • FIGURE 12 RISING AWARENESS ABOUT PERSONAL PROTECTIVE EQUIPMENT AND INCREASING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE GLOBAL INFECTION CONTROL MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 69
  • FIGURE 13 STERILIZATION PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL INFECTION CONTROL MARKET IN 2020 & 2027 69
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR INFECTION CONTROL DEVELOPERS IN THE FORECAST PERIOD OF 2020 TO 2027 70
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF GLOBAL INFECTION CONTROL MARKET 75
  • FIGURE 16 GLOBAL INFECTION CONTROL MARKET: BY PRODUCT, 2019 86
  • FIGURE 17 GLOBAL INFECTION CONTROL MARKET: BY PRODUCT, 2019-2027 (USD MILLION) 87
  • FIGURE 18 GLOBAL INFECTION CONTROL MARKET: BY PRODUCT, CAGR (2020-2027) 87
  • FIGURE 19 GLOBAL INFECTION CONTROL MARKET: BY PRODUCT, LIFELINE CURVE 88
  • FIGURE 20 GLOBAL INFECTION CONTROL MARKET : BY APPLICATION, 2019 105
  • FIGURE 21 GLOBAL INFECTION CONTROL MARKET : BY APPLICATION, 2019-2027 (USD MILLION) 106
  • FIGURE 22 GLOBAL INFECTION CONTROL MARKET : BY APPLICATION, CAGR (2020-2027) 106
  • FIGURE 23 GLOBAL INFECTION CONTROL MARKET : BY APPLICATION, LIFELINE CURVE 107
  • FIGURE 24 GLOBAL INFECTION CONTROL MARKET: BY DISTRIBUTION CHANNEL, 2019 112
  • FIGURE 25 GLOBAL INFECTION CONTROL MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION) 113
  • FIGURE 26 GLOBAL INFECTION CONTROL MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 113
  • FIGURE 27 GLOBAL INFECTION CONTROL MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 114
  • FIGURE 28 GLOBAL INFECTION CONTROL MARKET: BY END USER, 2019 118
  • FIGURE 29 GLOBAL INFECTION CONTROL MARKET: BY END USER, 2019-2027 (USD MILLION) 119
  • FIGURE 30 GLOBAL INFECTION CONTROL MARKET: BY END USER, CAGR (2020-2027) 119
  • FIGURE 31 GLOBAL INFECTION CONTROL MARKET: BY END USER, LIFELINE CURVE 120
  • FIGURE 32 GLOBAL INFECTION CONTROL MARKET: SNAPSHOT (2019) 127
  • FIGURE 33 GLOBAL INFECTION CONTROL MARKET: BY COUNTRY (2019) 128
  • FIGURE 34 GLOBAL INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 128
  • FIGURE 35 GLOBAL INFECTION CONTROL MARKET: BY COUNTRY (2019 & 2027) 129
  • FIGURE 36 GLOBAL INFECTION CONTROL MARKET: BY PRODUCT (2020-2027) 129
  • FIGURE 37 NORTH AMERICA INFECTION CONTROL MARKET: SNAPSHOT (2019) 131
  • FIGURE 38 NORTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2019) 132
  • FIGURE 39 NORTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 132
  • FIGURE 40 NORTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 133
  • FIGURE 41 NORTH AMERICA INFECTION CONTROL MARKET: BY TYPE (2018-2027) 133
  • FIGURE 42 EUROPE INFECTION CONTROL MARKET: SNAPSHOT (2019) 154
  • FIGURE 43 EUROPE INFECTION CONTROL MARKET: BY COUNTRY (2019) 155
  • FIGURE 44 EUROPE INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 155
  • FIGURE 45 EUROPE INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 156
  • FIGURE 46 EUROPE INFECTION CONTROL MARKET: BY TYPE (2018-2027) 156
  • FIGURE 47 ASIA-PACIFIC INFECTION CONTROL MARKET: SNAPSHOT (2019) 214
  • FIGURE 48 ASIA-PACIFIC INFECTION CONTROL MARKET: BY COUNTRY (2019) 215
  • FIGURE 49 ASIA-PACIFIC INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 215
  • FIGURE 50 ASIA-PACIFIC INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 216
  • FIGURE 51 ASIA-PACIFIC INFECTION CONTROL MARKET: BY TYPE (2018-2027) 216
  • FIGURE 52 SOUTH AMERICA INFECTION CONTROL MARKET: SNAPSHOT (2019) 274
  • FIGURE 53 SOUTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2019) 275
  • FIGURE 54 SOUTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 275
  • FIGURE 55 SOUTH AMERICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 276
  • FIGURE 56 SOUTH AMERICA INFECTION CONTROL MARKET: BY TYPE (2018-2027) 276
  • FIGURE 57 MIDDLE EAST & AFRICA INFECTION CONTROL MARKET: SNAPSHOT (2019) 293
  • FIGURE 58 MIDDLE EAST & AFRICA INFECTION CONTROL MARKET: BY COUNTRY (2019) 294
  • FIGURE 59 MIDDLE EAST & AFRICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 294
  • FIGURE 60 MIDDLE EAST & AFRICA INFECTION CONTROL MARKET: BY COUNTRY (2020 & 2027) 295
  • FIGURE 61 MIDDLE EAST & AFRICA INFECTION CONTROL MARKET: BY TYPE (2018-2027) 295
  • FIGURE 62 GLOBAL INFECTION CONTROL MARKET: COMPANY SHARE 2019 (%) 328
  • FIGURE 63 NORTH AMERICA INFECTION CONTROL MARKET: COMPANY SHARE 2019 (%) 329
  • FIGURE 64 EUROPE INFECTION CONTROL MARKET: COMPANY SHARE 2019 (%) 330
  • FIGURE 65 ASIA-PACIFIC INFECTION CONTROL MARKET: COMPANY SHARE 2019 (%) 331